Nearly 10% of the 216,000 inmates are receiving medications designed to treat an array of illnesses, from depression and bipolar disorder to acute schizophrenia. The BOP's disclosure comes as government officials have raised questions about the costs of confining such large populations, while advocates for the mentally ill argue that prisons and jails have become the new repository for people with mental illness. [read the full story here]